Australia: Norton Rose Fulbright Advises Australian medicinal cannabis company Althea Group Holdings Limited on its IPO and listing on the ASX

“Chris and his team understood from early on the challenges Althea faced, given the newness of industry and complexities to do with patient access. We are thankful Norton Rose Fulbright were able to help guide Althea through the listing process and are proud to offer Australian’s from all walks of life the opportunity to invest in Australia’s premier licensed cannabis producer.”


Go to Source

Powered by WPeMatico